Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Bioorganic & Medicinal Chemistry Letters
|
March 29, 2013
Structure-based design and optimization of 2-aminothiazole-4-carboxamide as a new class of CHK1 inhibitors
Xiaohua Huang, Cliff C Cheng, Thierry O Fischmann, et al.
Biochemistry
|
August 20, 2010
Novel benzimidazole inhibitors bind to a unique site in the kinesin spindle protein motor domain
Payal R Sheth, Gerald W Shipps, Wolfgang Seghezzi, et al.
Journal of Lipid Research
|
February 8, 2011
Small-molecule inhibitors of FABP4/5 ameliorate dyslipidemia but not insulin resistance in mice with diet-induced obesity
Hong Lan, Cliff C Cheng, Timothy J Kowalski, et al.
Journal of Medicinal Chemistry
|
October 15, 2014
Discovery of novel, dual mechanism ERK inhibitors by affinity selection screening of an inactive kinase
Yongqi Deng, Gerald W Shipps, Alan Cooper, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 17, 2013
Modulating the interaction between CDK2 and cyclin A with a quinoline-based inhibitor
Yongqi Deng, Gerald W Shipps, Lianyun Zhao, et al.
ACS Medicinal Chemistry Letters
|
March 18, 2016
Discovery of Novel 3,3-Disubstituted Piperidines as Orally Bioavailable, Potent, and Efficacious HDM2-p53 Inhibitors
Stéphane L Bogen, Weidong Pan, Craig R Gibeau, et al.
JCI Insight
|
February 23, 2018
Development of MK-8353, an orally administered ERK1/2 inhibitor, in patients with advanced solid tumors
Stergios J Moschos, Ryan J Sullivan, Wen-Jen Hwu, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 20, 2010
Structure and activity relationships of tartrate-based TACE inhibitors
Dansu Li, Janeta Popovici-Muller, David B Belanger, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 22, 2009
The discovery of novel tartrate-based TNF-alpha converting enzyme (TACE) inhibitors
Kristin E Rosner, Zhuyan Guo, Peter Orth, et al.
ACS Medicinal Chemistry Letters
|
July 24, 2018
MK-8353: Discovery of an Orally Bioavailable Dual Mechanism ERK Inhibitor for Oncology
Sobhana Babu Boga, Yongqi Deng, Liang Zhu, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Bioorganic & Medicinal Chemistry Letters
|
March 29, 2013
Structure-based design and optimization of 2-aminothiazole-4-carboxamide as a new class of CHK1 inhibitors
Xiaohua Huang, Cliff C Cheng, Thierry O Fischmann, et al.
Biochemistry
|
August 20, 2010
Novel benzimidazole inhibitors bind to a unique site in the kinesin spindle protein motor domain
Payal R Sheth, Gerald W Shipps, Wolfgang Seghezzi, et al.
Journal of Lipid Research
|
February 8, 2011
Small-molecule inhibitors of FABP4/5 ameliorate dyslipidemia but not insulin resistance in mice with diet-induced obesity
Hong Lan, Cliff C Cheng, Timothy J Kowalski, et al.
Journal of Medicinal Chemistry
|
October 15, 2014
Discovery of novel, dual mechanism ERK inhibitors by affinity selection screening of an inactive kinase
Yongqi Deng, Gerald W Shipps, Alan Cooper, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 17, 2013
Modulating the interaction between CDK2 and cyclin A with a quinoline-based inhibitor
Yongqi Deng, Gerald W Shipps, Lianyun Zhao, et al.
ACS Medicinal Chemistry Letters
|
March 18, 2016
Discovery of Novel 3,3-Disubstituted Piperidines as Orally Bioavailable, Potent, and Efficacious HDM2-p53 Inhibitors
Stéphane L Bogen, Weidong Pan, Craig R Gibeau, et al.
JCI Insight
|
February 23, 2018
Development of MK-8353, an orally administered ERK1/2 inhibitor, in patients with advanced solid tumors
Stergios J Moschos, Ryan J Sullivan, Wen-Jen Hwu, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 20, 2010
Structure and activity relationships of tartrate-based TACE inhibitors
Dansu Li, Janeta Popovici-Muller, David B Belanger, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 22, 2009
The discovery of novel tartrate-based TNF-alpha converting enzyme (TACE) inhibitors
Kristin E Rosner, Zhuyan Guo, Peter Orth, et al.
ACS Medicinal Chemistry Letters
|
July 24, 2018
MK-8353: Discovery of an Orally Bioavailable Dual Mechanism ERK Inhibitor for Oncology
Sobhana Babu Boga, Yongqi Deng, Liang Zhu, et al.
Page
of 3